Prospective observational multicenter study of patients with AH and CKD markers in Kazakhstan (PROGRESS-CKD)

Trial Identifier: D1843R00359
Sponsor: AstraZeneca
Start Date: January 2025
Primary Completion Date: August 2026
Study Completion Date: August 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Kazakhstan Almaty, Kazakhstan
Kazakhstan Astana, Kazakhstan
Kazakhstan Issyk, Kazakhstan
Kazakhstan Karaganda, Kazakhstan
Kazakhstan Kostanay, Kazakhstan
Kazakhstan Semey, Kazakhstan
Kazakhstan Shymkent, Kazakhstan
Kazakhstan Stepnogorsk, Kazakhstan
Kazakhstan Turkestan, Kazakhstan
Kazakhstan Uzynagash, Kazakhstan
Kazakhstan, Turkestan region Temirlanovka, Turkestan region, Kazakhstan